Seeing Is Believing
Currently out of the existing stock ratings of David Rescott, 105 are a BUY (85.37%), 18 are a HOLD (14.63%).
Analyst David Rescott, currently employed at BAIRD, carries an average stock price target met ratio of 62.43% that have a potential upside of 22.44% achieved within 141 days. Previously, David Rescott worked at TRUIST.
David Rescott’s has documented 263 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PEN, Penumbra at 30-Jul-2025.
Analyst best performing recommendations are on IRTC (IRHYTHM TECHNOLOGIES).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 10/31/2024. The price target of $85 was fulfilled within 5 days with a profit of $12.56 (17.34%) receiving and performance score of 34.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$100
$8.76 (9.60%)
$98
27 days ago
(16-Jul-2025)
0/6 (0%)
$10.22 (11.38%)
Buy
$99
$7.76 (8.51%)
$107
1 months 3 days ago
(09-Jul-2025)
9/19 (47.37%)
$10 (11.24%)
499
Buy
$106
$14.76 (16.18%)
$104
1 months 4 days ago
(08-Jul-2025)
3/6 (50%)
$17.42 (19.67%)
920
Hold
2 months 6 days ago
(06-Jun-2025)
7/11 (63.64%)
$30.52 (32.65%)
781
Hold
$92
$0.76 (0.83%)
$91
2 months 21 days ago
(22-May-2025)
5/8 (62.5%)
$11.09 (13.71%)
138
Which stock is David Rescott is most bullish on?
Which stock is David Rescott is most reserved on?
What Year was the first public recommendation made by David Rescott?